Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Launch of a strategic reviewMid-term perspectives suspended1PARIS--(BUSINESS WIRE)--Regulatory News:The Board of Directors of EUROAPI (Paris:EAPI) met today to review the most recent full-year 2023 results forecasts. As a result of this review, the company provides the following update2.The full-year 2023 outlook is...
The Goldman Sachs Group lowered shares of Shenzhen Hepalink Pharmaceutical Group (OTCMKTS:SHEZF – Free Report) from a neutral rating to a sell rating in a research report sent to investors on Thursday morning, FlyOnTheWall reports. Shenzhen Hepalink Pharmaceutical Group Stock Performance SHEZF opened at $0.72 on Thursday. Shenzhen Hepalink Pharmaceutical Group has a twelve month […]
NorthStar Medical Radioisotopes, LLC will suspend manufacturing and commercialization of molybdenum-99 (Mo-99) by the end of 2023, the company announced Thursday.
LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--Altasciences is pleased to welcome Angel Reyes as General Manager, Contract Development and Manufacturing Organization (CDMO) Services.Angel joins Altasciences having previously been the Director of Operations at Catalent. He brings to Altasciences over a decade of expe...
Kotak Institutional Equities has cut its FY2024-26E EPS estimate for Navin Fluorine, citing possible delays in growth projects. Jefferies has downgraded the stock to 'hold' from 'buy' and reduced the target price to Rs 3,625 from Rs 5,475